Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: For human use
Package code: 1362440
Name of medicinal product: ADROVANCE
Active substances:
Alendronic acid+Colecalciferol
Estonian, English, Latin
ATC code: M05BB03
Dosage form: tablet
Route of administration: oral use
Strengh: 70mg+5600RÜ
Amount in package: 4TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: ADROVANCE is indicated for the treatment of postmenopausal osteoporosis in women who are not receiving vitamin D supplementation and are at risk of vitamin D insufficiency. ADROVANCE reduces the risk of vertebral and hip fractures.
Safety features: Yes
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Last imported to Estonia: Never imported to Estonia
Marketing authorization holder: Organon N.V. 
Marketing authorization number: EU/1/06/364 
Marketing authorization issued on: October 2, 2007 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Centralised 
Reference price:   
Under reference price:   
Reference price of daily dose:   
Entry/Changing date: May 19, 2021
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere